A Randomized Trial of Intracoronary Reopro to Improve Coronary Microvascular Function
NCT02105870
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Myocardial Infarction
Coronary Artery Disease
Interventions
DRUG:
Abciximab
Sponsor
University of Melbourne